...
首页> 外文期刊>Neoplasma: Journal of Experimental and Clinical Oncology >Expression and prognostic significance of Cathepsin L in early cutaneous malignant melanoma.
【24h】

Expression and prognostic significance of Cathepsin L in early cutaneous malignant melanoma.

机译:组织蛋白酶L在早期皮肤恶性黑色素瘤中的表达及预后意义。

获取原文
获取原文并翻译 | 示例
           

摘要

Cathepsins are papain-like lysosome cystein proteases involved in tumor growth, invasiveness and spread, angiogenesis and alteration in immune and inflammatory responses. We investigated the differences in cathepsin L (CatL) concentrations in primary cutaneous malignant melanoma stage I and normal skin and correlated these values with well-established malignant melanoma prognostic factors. The study was performed on 36 patients (17 men and 19 women; mean age 54 years; range 21-84 years) with histological confirmed primary malignant melanomas less than 1.5 mm thick. The CatL concentrations were measured in 36 pairs of triton extracts of cytosols prepared from the tumor and adjacent normal tissue samples (matched pairs). The CatL concentrations were determined by commercially available enzyme-liked immunosorbent (ELISA) assay from KRKA (Novo Mesto, Slovenia). Significantly higher concentrations of CatL were detected in malignant melanomas than in normal surrounding skin (6.73 vs. 1.42 ng/mg total protein(mgp), p<0.001). Significant correlations between malignant melanoma and normal skin concentrations for CatL were found. The malignant melanoma CatL concentrations correlated significantly with normal skin (r=0.38; p=0.021). CatL concentrations were significantly lower (p<0.01) in the malignant melanomas of Breslow thickness <=0.75 mm, Clark invasion 0.75 mm, Clark invasion of >=II and <=III, with microscopic ulceration and with vascular invasion (7.67, 7.41, 9.15, 10.35 ng/mgp, respectively). Higher CatL concentrations in early primary malignant melanomas indicate its possible involvement in the processes of early metastatic spread and its association with poor prognosis.
机译:组织蛋白酶是木瓜蛋白酶样的溶酶体半胱氨酸蛋白酶,参与肿瘤的生长,侵袭和扩散,血管生成以及免疫和炎症反应的改变。我们调查了一级皮肤恶性黑色素瘤I期和正常皮肤中组织蛋白酶L(CatL)浓度的差异,并将这些值与公认的恶性黑色素瘤预后因素相关联。该研究针对36例经组织学确认为厚度小于1.5毫米的原发性恶性黑色素瘤患者(男17例,女19例;平均年龄54岁;范围21-84岁)进行。在从肿瘤和邻近的正常组织样品(匹配对)制备的36对胞浆的triton提取物中测量CatL浓度。通过可购自KRKA(斯洛文尼亚,Novo Mesto)的酶样免疫吸附剂(ELISA)测定法确定CatL浓度。在恶性黑色素瘤中检测到的CatL浓度显着高于正常周围皮肤(6.73对1.42 ng / mg总蛋白(mgp),p <0.001)。发现恶性黑色素瘤与CatL的正常皮肤浓度之间存在显着相关性。恶性黑色素瘤CatL浓度与正常皮肤显着相关(r = 0.38; p = 0.021)。在Breslow厚度<= 0.75 mm,Clark入侵 0.75 mm,克拉克浸润> = II和<= III的恶性黑色素瘤,有微小溃疡和血管浸润(分别为7.67、7.41、9.15、10.35 ng / mgp)。早期原发性恶性黑色素瘤中较高的CatL浓度表明其可能参与了早期转移性扩散的过程以及与不良预后的关联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号